NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry.

Author(s): Schaub S, Wilkins J, Weiler T, Sangster K, Rush D, Nickerson P

Publication: Kidney Int, 2004, Vol. 65, Page 323

PubMed ID: 14675066 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine if the urine protein profile, as determined by surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS), was influenced by patient (gender, blood in the urine, urine dilution), acquisition (sequential collection), storage (duration, freeze thaw cycling), or analytical factors (matrix composition, instrument settings).

Conclusion of Paper

The authors report that matrix composition and instrument settings affected peak detection and reproducibility. While 5 freeze-thaw cycles resulted in a loss of peaks, 4 cycles or less had minimal effects on urine protein profiles. Effects of storage duration were dependent upon gender and sequential collection: storage of mid-stream specimens for 3 days at 4 degrees C yielded little to no effect in terms of the number of peaks observed, while storage of first stream samples resulted in new low molecular weight peaks; and comparison among first and mid-stream specimens yielded differences in the spectral profile for females alone. The presence of blood in the urine specimen introduced new peaks corresponding to serum proteins. Fluid loading that exceeded 2L per day also impacted the spectral profile of urine specimens.

Studies

  1. Study Purpose

    The purpose of this paper was to determine if the urine protein profile, as determined by surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS), was influenced by analytical factors (matrix composition, instrument settings).

    Summary of Findings:

    Varying concentrations (20-100%) of matrix solutions resulted in a universal effect on observed peak number. Spot sampling protocol also influenced peak number in diluted and undiluted urine specimens.

    Biospecimens
    Preservative Types
    • Frozen
    Diagnoses:
    • Not specified
    Platform:
    AnalyteTechnology Platform
    Protein SELDI-TOF MS
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    SELDI-TOF MS Specific Reaction solution 20%, 35%, 50%, or 100% CHCA
    20%, 35%, 50%, or 100% SPA
    Biospecimen Aliquots and Components Aliquot size/volume Undiluted urine
    Concentrated urine
    Diluted urine (1:2)
    Diluted urine (1:4)
    Diluted urine (1:8)
    Diluted urine (1:16)
  2. Study Purpose

    The purpose of this paper was to determine if the urine protein profile, as determined by surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS), was influenced by patient (gender, blood in the urine, urine dilution), or acquisition related factors (sequential collection).

    Summary of Findings:

    First stream urine specimens collected from females only differed from mid-stream specimens in the 3-3.5 kD range. Storage of mid-stream urine specimens for 3 days at room temperature or 4 degrees C yielded little to no effect in terms of the number of peaks observed, while storage of first stream specimens resulted in new low molecular weight peaks. Five freeze thaw cycles resulted in a loss of peaks while 4 or less freeze thaw cycles did not significantly alter spectral profiles. The presence of blood in urine specimens resulted in the appearance of peaks consistent with serum proteins. Fluid loading of 4L per day affected the spectral profile while 2L per day had little effect.

    Biospecimens
    Preservative Types
    • Frozen
    Diagnoses:
    • Normal
    Platform:
    AnalyteTechnology Platform
    Protein SELDI-TOF MS
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Aliquots and Components Aliquot sequential collection First-void urine (the first 10-20 ml excreted)
    Mid-stream urine (the next 50-80 ml excreted)
    Preaquisition Patient gender Female
    Male
    Storage Storage duration Processing within 2 h of collection
    3 days
    Storage Storage temperature 4 degrees C
    Room temperature
    -70 degrees C
    Storage Freeze/thaw cycling 1 freeze-thaw cycles
    2 freeze-thaw cycles
    3 freeze-thaw cycles
    4 freeze-thaw cycles
    5 freeze-thaw cycles
    Biospecimen Aliquots and Components Blood and blood products Presence of blood in urine specimen

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...